Gitte L. Pedersen
Fondateur chez Genomic Expression, Inc.
Profil
Gitte L.
Pedersen founded Genomic Expression, Inc. in 2012, where she is working as Chief Executive Officer & Director from 2012.
Ms. Pedersen also currently works at ExpreS2ion Biotechnologies ApS, as Independent Director.
Ms. Pedersen also formerly worked at Expres2ion Biotech Holding AB, as Director and Novo Nordisk A, as Head-Marketing from 1987 to 1997.
Ms. Pedersen received her graduate degree from Technical University of Denmark.
Postes actifs de Gitte L. Pedersen
| Sociétés | Poste | Début |
|---|---|---|
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Directeur/Membre du Conseil | - |
Genomic Expression, Inc.
 Genomic Expression, Inc. Pharmaceuticals: MajorHealth Technology Genomic Expression, Inc. is an American company that specializes in RNA analysis to detect diseases, monitor health, and design next-generation cures. The company offers COVID19 PCR testing as well as cancer testing. The company was founded by Gitte L. Pedersen and Morten Lorentz Pedersen, with Gitte L. Pedersen serving as the CEO since incorporation. | Fondateur | 01/08/2012 |
Anciens postes connus de Gitte L. Pedersen
| Sociétés | Poste | Fin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur/Membre du Conseil | 26/05/2021 |
| NOVO NORDISK A/S | Sales & Marketing | 01/06/1997 |
Formation de Gitte L. Pedersen
| Technical University of Denmark | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Entreprise privées | 2 |
|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
Genomic Expression, Inc.
Genomic Expression, Inc. Pharmaceuticals: MajorHealth Technology Genomic Expression, Inc. is an American company that specializes in RNA analysis to detect diseases, monitor health, and design next-generation cures. The company offers COVID19 PCR testing as well as cancer testing. The company was founded by Gitte L. Pedersen and Morten Lorentz Pedersen, with Gitte L. Pedersen serving as the CEO since incorporation. | Health Technology |